Company Search:
Advanced Search
Sponsored Links
Oasmia Pharmaceutical AB - ADR Company Snapshot
Oasmia Pharmaceutical AB operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oasmia Pharmaceutical AB with three other pharmaceutical manufacturers in North America: Chemistree Technology Inc of Canada (2019 sales of 317,736.00 Canadian Dollars [US$239,982.82 ] of which 100% was Investment), Alterity Therapeutics Ltd ($77,573.19 ), and Sangui Biotech International, Incorporated ($88,001.00 ).

Sales Analysis. Oasmia Pharmaceutical AB reported sales of $218,512.80 for the fiscal year ending April of 2019. This represents a sharp decrease of 42.9% versus 2018, when the company's sales were $382,593.37 .
  Stock Performance Chart for Oasmia Pharmaceutical AB - ADR
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): .60
(Figures in U.S. Dollars)
1 Week -60.8%   13 Weeks -52.0%  
4 Weeks -64.1%   52 Weeks -83.1%  
Oasmia Pharmaceutical AB - ADR Key Data:
  Ticker: OASMY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 218,513
(Year Ending Jan 2020).
Employees: 60
  Currency: U.S. Dollars Market Cap: 68,550,333
  Fiscal Yr Ends: April Shares Outstanding: 114,212,484
  Share Type: ADR Closely Held Shares: 36,706,938
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.